Milestone Ophthalmic Sp. z o.o. agreed to acquire Emmerson Wierzytelnosci Hipoteczne S.A. (WSE:EWH) (‘EWH') in a reverse merger transaction on September 22, 2014. As a part of transaction, Milestone Ophthalmic plans to merge with Emmerson to effect a listing of its common stock on the New Connect market of the Warsaw Stock Exchange, subject to certain final terms and conditions of the merger agreement. Post acquisition Emmerson Wierzytelnosci Hipoteczne will change its name to Advanced Ocular Sciences S.A. In connection with the transaction, EWH will hold a general meeting of shareholders on September 26, 2014 in which the majority shareholders are expected to approve the name change and vote for new management and supervisory Board members, including individuals affiliated with Milestone Scientific, Inc. (OTCQB: MLSS) and Astoria Capital S.A., shareholders of Milestone Ophthalmic. David Waldman or Natalya Rudman of Crescendo Communications, LLC served as the public relations contacts on the deal for Milestone Scientific.

Milestone Ophthalmic Sp. z o.o. completed the acquisition of Emmerson Wierzytelnosci Hipoteczne S.A. (WSE:EWH) (‘EWH') in a reverse merger transaction on November 26, 2014.